From Risk to Resilience: Healthcare Providers and the Psychedelic Therapy Revolution
Treatment
Currently, MDMA-assisted therapy for PTSD and psilocybin for depression disorders await approval from the FDA. Meanwhile, practitioners are creating spaces to give their patients this revolutionary experience.
Leave a Reply
Want to join the discussion?Feel free to contribute!